Watch this video for PCPA members

Cardiovascular Disease: Identifying and Prioritising Patients for Optimal Lipid Management

Prevention is at the heart of NHS Long Term Plan and the foundation for many regional and local plans to tackle key population health issues, including cardiovascular disease.

With the roll out of CVDPrevent audits and indicators, primary care teams must look at ways to improve the diagnosis and management of six high risk conditions, including cholesterol management. This webinar looks at how our customers are using AnalyseRx to find high risk cohorts requiring cholesterol optimisation as part of their long-term condition management plans.

About FDB AnalyseRx

• Deep integration with EMIS enables automatic, daily data updates
• Easily and accurately find priority cases as cohorts or individual patients
• Reduce risk and increase consistency with trusted evidence-based clinical content and coding
• Improve audit and indicator performance in key clinical areas
• View patient progress and report on activities completed
• Sophisticated analytics delivering insights at every system level

FDB's Primary Care Solutions

Supporting primary care teams with market leading clinical decision support solutions

FDB AnalyseRx

AnalyseRx is the first solution fully integrated into EMIS Web to help NHS primary care teams proactively identify and easily action medicines optimisation opportunities across a patient population.

With AnalyseRx, primary care teams can quickly gain insight to determine priorities and then coordinate and manage every step in the medicines optimisation process, all within EMIS Web. Patient data is automatically refreshed daily, enabling teams to spend more time focusing on the patients identified and less time on data manipulation. Ultimately, this leads to increased productivity, more time for patient care and better clinical outcomes at every level of your organisation.

Download the brochure to find out more: https://pcpa.co/FDBAnalyseRX22

FDB OptimiseRx

OptimiseRx is the only truly patient-specific medicines optimisation solution to deliver cost savings while driving up the quality of prescribing.

OptimiseRx is currently available in more than 4500 GP Practices across the UK, covering 44 million patients. OptimiseRx combines national guidance and the best available evidence with locally authored formularies and policies. GPs benefit from more targeted and expertly authored medicines information that supports their clinical decisions, whilst Medicines Optimisation Teams can improve consistency, compliance and formulary adherence to help them achieve their cost and quality objectives.

Download the brochure to find out more: https://pcpa.co/FDBOptimiseRX23

Latest Press Releases

FDB's OptimiseRx achieves savings of £300 million for the NHS: FDB's OptimiseRx achieves savings of £300 million for the NHS | FDB (First Databank) (fdbhealth.co.uk)

FDB announces partnership with PRSB: FDB announces partnership with PRSB | FDB (First Databank) (fdbhealth.co.uk)

Tech helps GPs reduce diabetes and stroke incidence through improved antipsychotic prescribing: Tech helps GPs reduce diabetes and stroke incidence through improved antipsychotic prescribing | FDB (First Databank) (fdbhealth.co.uk)